EVGN - Evogene Ltd.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
3.1000
0.0000 (0.00%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close3.1000
Open3.0900
Bid0.0000 x 1000
Ask0.0000 x 900
Day's Range3.0899 - 3.1000
52 Week Range2.5900 - 4.7500
Volume1,633
Avg. Volume8,073
Market Cap79.034M
Beta0.31
PE Ratio (TTM)N/A
EPS (TTM)-0.8310
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.00
Trade prices are not sourced from all markets
  • GlobeNewswire16 days ago

    Evogene Announces a Significant Milestone in its Next Generation Herbicide Pipeline

    Evogene Ltd. (NASDAQ, TASE: EVGN), a leading biotechnology company developing novel products for life science markets, announced today a significant milestone in its next generation herbicide pipeline. Evogene’s Ag-Chemicals division demonstrated biological proof in lab assays that Evogene discovered molecule families bind to essential target proteins representing new MoA’s (Mode-of-Action). Herbicides are weed killing chemicals, part of the general pesticide and crop protection market.

  • Associated Presslast month

    Evogene: 2Q Earnings Snapshot

    On a per-share basis, the Rehovot, Israel-based company said it had a loss of 19 cents. The agricultural company posted revenue of $379,000 in the period. The company's shares closed at $2.88. A year ago, ...

  • GlobeNewswirelast month

    Evogene Reports Second Quarter 2018 Financial Results

    REHOVOT, Israel, Aug. 08, 2018-- Evogene Ltd., a leading biotechnology company developing novel products for life science markets, announced today its financial results for the second quarter ending June ...

  • ACCESSWIRElast month

    Evogene Ltd to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Evogene Ltd (NASDAQ: EVGN ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 9:00 AM Eastern Time. To listen ...

  • GlobeNewswire2 months ago

    Evogene Financial Results for the Second Quarter of 2018

    REHOVOT, Israel, July 18, 2018-- Evogene Ltd., a leading biotechnology company developing novel products for life science markets, announced today that it will release its financial results for the second ...

  • GlobeNewswire2 months ago

    Evogene and IMAmt Enter a Collaboration in the Field of Insect Resistance Traits in Cotton

    REHOVOT, Israel and CUIABÁ/MT, Brazil, July 17, 2018-- Evogene Ltd., a leading biotechnology company developing novel products for life science markets, and Instituto Mato-grossense do Algodão, a leading ...

  • GlobeNewswire2 months ago

    Evogene Announces Positive Yield Results in its Bio-Stimulant Program for Wheat

    REHOVOT, Israel, July 10, 2018-- Evogene Ltd., a leading biotechnology company developing novel products for life science markets, announced today that its Ag-Biologicals division has achieved positive ...

  • ACCESSWIRE4 months ago

    Blog Exposure - Evogene Signs Collaboration Agreement with BASF for Development of Novel Insecticides

    LONDON, UK / ACCESSWIRE / May 31, 2018 / If you want access to our free research report on Evogene Ltd (NASDAQ: EVGN), all you need to do is sign up now by clicking the following link www.active-investors.com/registration-sg/?symbol=EVGN as the Company's latest news hit the wire. On May 29, 2018, the Company, which is a leading biotechnology organization developing novel products for life science markets, and BASF, which is one of the world's leading chemical Companies, declared on May 29, 2018, that they have signed a new collaboration agreement for the development of novel insecticides based on new binding areas (Site-of-Action or ‘SoA') on key insecticidal target proteins. Active-Investors.com is currently working on the research report for Oncobiologics, Inc. (NASDAQ: ONS), which also belongs to the Healthcare sector as the Company Evogene.

  • Associated Press4 months ago

    Evogene: 1Q Earnings Snapshot

    On a per-share basis, the Rehovot, Israel-based company said it had a loss of 21 cents. The agricultural company posted revenue of $366,000 in the period. The company's shares closed at $3.10. A year ago, ...

  • Associated Press7 months ago

    Evogene reports 4Q loss

    The Rehovot, Israel-based company said it had a loss of 24 cents per share. The agricultural company posted revenue of $734,000 in the period. For the year, the company reported that its loss widened to ...

  • ACCESSWIRE7 months ago

    Evogene Ltd to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / February 28, 2018 / Evogene Ltd (NASDAQ: EVGN ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 28, 2018 at 9:00 AM Eastern Time. ...